chrisvoncsefalvay/vaers-outcomes huggingface dataset:
runny nose; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), NAUSEA (nausea) and VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (No reported medical history.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced RHINORRHOEA (runny nose), NAUSEA (nausea) and VOMITING (vomiting). At the time of the report, RHINORRHOEA (runny nose), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported.  No treatment information was provided.
Pt states she has soreness in both arms since she received the vaccinations.  Her right arm constantly hurts and her left arm has pain that comes and goes.
8/12/21 ADMITTED TO MEDICAL CENTER WITH COVID SYMPTOMS X10 DAYS. RM AIR O2 SATS = 80S ON ADMIT. DX+ PNEUMONIA
3-30-21 1:56 PM PT FEELS 'LIGHT HEADED'. PLACED ON FLOOR AND ELEVATED FEET.  2:03PM 'FEELING BETTER NOW'. W/D, NO SOB. 2:08PM ATTEMPTED TO SIT UP AND BECAME 'WOOZY & NAUSEATED'.  TOOK 2 PUFFS OF HER INHALER. RASH NOTED TO HER NECK - BENADRYL 50MG GIVEN PO. 2:16PM TO ER PER SQUAD. PT PINK, W/D, NO RESP DISTRESS. 3-31-21 10AM TC: PT STATES SHE WAS 'TREATED AND RELEASED FROM ER AND FEELS BETTER TODAY'.
Unusually severe Lyme disease-high Lyme disease since. And on May of 2002 became so sick was treated for Lyme with first doxycyclin for 20 days. Then 42 days of Rocephrin IV antibiotics. Blood count still high positive Lyme.
Approximately 4-5 days after vaccination, the skin of my face, scalf and around my eyes became itchy.  I think there's very minor puffiness of my upper cheeks at either side of my nose.  Now, ten days later, the itching persists.
Mother called in today stated "the day he got his shot (6-24-10) she noticed raised welts in his diaper area, few on legs and one on face, she treated them with BENADRYL cream et they would go away then 4 hrs later came back and she would use the cream again and they would go away again. She denied the child had pain or fever, said "you couldn't tell anything was wrong". Also said he never c/o itching. She did say that she had introduced plain peanut butter to the child the same day. So didn't know for sure which if either caused the welts.
This spontaneous report was received from a registered nurse, concerning unspecified number of patients of unknown age and gender. There were no concurrent conditions, medical history, drug reactions, allergies or concomitant medications reported. On unspecified dates, the patients were vaccinated with an improperly stored dose of VAQTA (dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. The temperature of the VAQTA was of 19 °C for a time frame of 11 hours. Previous temperature excursion occurred; however, the temperature information was unknown by the reporter. No data logger was involved. No adverse effects were reported. This is one of five reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1705USA007283: US-009507513-1705USA008598: US-009507513-1705USA008600: US-009507513-1705USA008605.
PT RECEIVED VACCINE ON02/04/21. NEXT AM PT STAETED FEELING SLIGHT RINGING IN THE EAR BUT BY AFTERNOON IT GOT WORSE SO PT CALLED HER MD WHO PRESCIBED STEROID UNTIL PT WILL SEE HER ENT MD FOR HEARING TEST ON 02/08/21. ENT MD WAS CLOSED SO
local site or injection became inflamed and swolen within an area of 2.5 inches in circumfernce. The area was noticably re and enlarged. The injection was given about 4 PM on wednesday and the redness, swelling and discomfort were noticed about 2 hours later. The discomfort redness and swelling have decreased though are still noticable on sat. evening about 11 PM. Cold compresses were used. Slightly elevated body temperature was experience on We. and thursday.
Missed second shot in the 40 day window; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second shot in the 40 day window) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second shot in the 40 day window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second shot in the 40 day window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Felt funny; Fever; Chills; Diarrhea; Problem with speech; Problem with short term memory; Couldn't remember anything; Problem with leg and feet swelling; Blood pressure was sky high; Did not receive second dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt funny), PYREXIA (Fever), CHILLS (Chills), DIARRHOEA (Diarrhea) and SPEECH DISORDER (Problem with speech) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shellfish allergy. Concomitant products included FISH OIL for Memory impaired, CALCIUM, B-Complex and DIURETICS for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt funny), PYREXIA (Fever), CHILLS (Chills), DIARRHOEA (Diarrhea), SPEECH DISORDER (Problem with speech), AMNESIA (Problem with short term memory), MEMORY IMPAIRMENT (Couldn't remember anything), PERIPHERAL SWELLING (Problem with leg and feet swelling), BLOOD PRESSURE INCREASED (Blood pressure was sky high) and PRODUCT DOSE OMISSION ISSUE (Did not receive second dose). At the time of the report, FEELING ABNORMAL (Felt funny), PYREXIA (Fever), CHILLS (Chills), DIARRHOEA (Diarrhea), SPEECH DISORDER (Problem with speech), AMNESIA (Problem with short term memory), MEMORY IMPAIRMENT (Couldn't remember anything), PERIPHERAL SWELLING (Problem with leg and feet swelling), BLOOD PRESSURE INCREASED (Blood pressure was sky high) and PRODUCT DOSE OMISSION ISSUE (Did not receive second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: (High) Blood pressure was sky high.. On an unknown date, Computerised tomogram: (Negative) For stroke. On an unknown date, Magnetic resonance imaging: (Negative) For stroke.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitants are Blood pressure medication; cholesterol medication; gout medication; thyroid medications were reported. No concomitant medications were reported.
6/25/18 ADE note: short self-limiting tonic-clonic seizure observed minutes after administration of GARDASIL 9 first injection in the series.
patient states that his ribs hurt really bad and it hurts when he moves his diaphragm
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). An 81-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "product=COVID 19 Treatment, brand=Paxlovid/vaccine brand=Pfizer / BioNTech". Therapeutic measures were taken as a result of drug ineffective, Covid-19. Clinical course: The patient took Blood Pressure medication (unspecified) in 2 weeks, had no known allergies. The patient took COVID-19 treatment with Paxlovid (treatment start date- 25May2022, treatment stop date- 29May2022). The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient admitted to hospital on 10/31/09 for right upper lobe pneumonia/atelectasis. She had fever on 10/24/09 to 101F and fever to 105F on 10/25/09 for which she was seen at ER where nasal swab was perfomed and she was given tamiflu. She followed up with her primary physician who felt she had a pneumonia and gave her 3 days of rocephin followed by augmentin. However, she did not improve with continued fevers so she was admitted for futher evaluation and management. She never required oxgyen. She did have right upper lobe atelectasis and clinically a pneumonia. She was discharged on 11/2/09 to complete 10 day course of antibiotics. She will complete a 5 day course of tamiflu.  11/02. FInal DX: Pneumonia, Goldenhaur Syndrome Pateint developed fever one day post vaccine. fever increased to 105.ONe dose Tamiflu.   IM abx given at PMD office x3. Persistent fever, chills, night sweats. Breath sounds decreased R side. Dyspnea.  Flu test neg.  11/16/2009 MR and DC summary for 10/31-11/02/2009.Dx Pneumonia patient with c/o's fever, CXR abnormal. Tx: IV ABX
I started getting a real bad pain - lymph node under my right arm. From my vaccine, I had a sore arm at the injection site. I had headaches for three or four days; pain in my ovaries - both sides; liver or kidneys - seemed to be going crazy - it was hurting around the same spot. I was taking Tylenol to help me but it wasn't helping me at all. I went for a CT scan (kidneys and ovaries looked okay)- no issues but they want me to see a specialist for liver - since I have fatty liver. I still have pain in my ovaries but not as bad as it was. I am waiting for a referral for the time for me to the liver specialist. My arm - right arm lymph node pain comes and goes still. I have a pretty high tolerance to pain but this was severe. I was taking cranberry juice to make sure I didn't get a UTI and lots of water.
patient experiencing body aches from head to toe along with severe fatigue, headache, sweating and tingling in her legs
Burning eyes, yellow discharge from eyes, very red eyes, sore throat, dizzy, severe body aches, chills.
Sudden hearing loss and ringing in my right ear. Occurred the day following my first dose of Moderna vaccine. Ended up resolving after about a day or two.
non-necrotizing (M-type) skin granuloma; Literature Report:  This literature marketed report has been received from the authors of a published literature article, titled as stated above and refers to a 12 year old patient of unknown gender with hemophagocytic lymphohistiocytosis (HLH). On an unknown date, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose and route not reported).         Rubella virus (RuV) has recently been found in association with granulomatous inflammation of the skin and several internal organs in patients with inborn errors of immunity (IEI). Several cases of IEI with granuloma formation have recently been identified in association with RuV vaccine strain RA27/3. Infectious immunodeficiency-related vaccine-derived rubella viruses (iVDRV) were isolated from granuloma biopsies and sequenced. Cutaneous granulomas are the most frequent manifestation diagnosed, but other organs including the liver, spleen, and lungs can also be affected. The aim of this study was to examine Rubella virus (RuV)-associated granulomas from 28 patients with inborn and acquired errors of immunity to determine whether specific inflammatory patterns localize to certain tissue sites or are associated with clinical characteristics.  On an unknown date, soon after vaccination, the patient experienced non-necrotizing (M-type) skin granuloma. Nasopharyngeal swab was positive for iVDRV. At the time of the report, the patient's outcome was unknown.  A copy of the published article is attached as further documentation of the patient's experience.  This is one of six reports received from the same article (MARRS 2201USA004372, 2202USA004886, 2202USA004887, 2202USA004888 and 2202USA004889).; Sender's Comments:  US-009507513-2201USA004372:
Pt experienced itching, mild swelling, and bright redness in throat within approximately 45 minutes. Pt given Epinephrine 0.3 mg IM and transferred to ED.
sore arm, knot on my arm, red and itchy in vaccination area, vomit, headaches, fever 103.
Extreme exhaustion, unable to think clearly, in a dream like state, body ache, muscle weakness and twitching, fever, nausea, vomiting
Redness on left arm injection site since 2nd primary dose; Tenderness on left arm injection site since 2nd primary dose/Left Arm Injection Site getting worst specially if she squeezes it; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness on left arm injection site since 2nd primary dose) and VACCINATION SITE PAIN (Tenderness on left arm injection site since 2nd primary dose/Left Arm Injection Site getting worst specially if she squeezes it) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on left arm injection site since 2nd primary dose) and VACCINATION SITE PAIN (Tenderness on left arm injection site since 2nd primary dose/Left Arm Injection Site getting worst specially if she squeezes it). At the time of the report, VACCINATION SITE ERYTHEMA (Redness on left arm injection site since 2nd primary dose) and VACCINATION SITE PAIN (Tenderness on left arm injection site since 2nd primary dose/Left Arm Injection Site getting worst specially if she squeezes it) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Since 2nd primary dose on 21-May-2021, she has redness and tenderness on injection site left arm. The arm was getting worst specially if she squeezes it. Patient was planning on seeing a doctor and has not reported to VAERS yet. As per the pharmacist, the patient has not received any other shots in the left arm since the second primary Moderna COVID-19 shot on 21-May-2021.  No treatment medications were reported.
On the evening December 22, 2022, I had a sore throat. On December 23, 2022, the sore throat got progressively worse. That persisted for about three days. I scheduled a telehealth appointment on December 26, 2022. I was prescribed Paxlovid due to testing positive on a rapid COVID-19 test at home. Three days later, my throat started feeling better. On day four, my sore throat was mild.
Tremendous fever,  headaches, and  chest pain. Also had MRI scan. Headaches continue for several months after shot with chest pain
I had terrible chills/horrible chills/Shivering; felt achy/aches all over; headache; pain at the injection site; arm stiff and sore; arm stiff and sore; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Apr2021 (Lot number: EP6955, Expiration Date: 30Jun2021) at the age of 69 years as dose 1, 0.3mg single for covid-19 immunisation. Relevant medical history included: "small TIA", start date: 2018 (unspecified if ongoing), notes: Verbatim: small TIA, Has had no issues from this.; "Covid-19", start date: Dec2020, stop date: Jan2021, notes: verbatim:COVID in the past December 2020 into January 2021 and she was very sick; "respiratory" (unspecified if ongoing), notes: Verbatim: respiratory issues her whole life. Concomitant medication(s) included: ATORVASTATIN CALCIUM (ongoing); BABY ASPIRIN (ongoing). Vaccination history included: Flu vaccination (but doesn't know what company it was from. never had any ill affects from.), for Immunisation. The following information was reported: CHILLS (non-serious) with onset 02Apr2021, outcome "recovered" (02Apr2021), described as "I had terrible chills/horrible chills/Shivering"; PAIN (non-serious) with onset 02Apr2021, outcome "recovering", described as "felt achy/aches all over"; HEADACHE (non-serious) with onset 02Apr2021, outcome "not recovered", described as "headache"; VACCINATION SITE PAIN (non-serious) with onset 01Apr2021, outcome "recovering", described as "pain at the injection site"; MUSCULOSKELETAL STIFFNESS (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 01Apr2021, outcome "recovering" and all described as "arm stiff and sore". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had inoculation yesterday morning. In the night she had terrible chills. she was shivering and felt achy. she had a headache and she still do. Consumer stated that she had the first dose yesterday of Pfizer COVID-19 and somewhere in middle of night she woke up with horrible chills, shivering and now has headache and aches all over. Consumer asked can she take Tylenol and would that be ok. Caller also added she had pain at the injection site that didn't bother her until she went to bed last night somewhere around 7pm and now it has improved but definitely hasn't gone away. Consumer stated she doesn't have chills and shivering anymore, it lasted about 2 hours and then went away. Started on 02APR2021 and ended on 02APR2021. The adverse events did not require any emergency room visit or physician office visit. No other vaccinations within four weeks prior to the first administration date of the suspect vaccine.  No follow-up attempts are possible. No further information is expected.
patient had fever, and swelling arms, fever, chills. patient had to go to emergency room. Patient told us that ER doctor gave her tylenol and allergy medications.
Pfizer dose was given beyond 72 days.  Pharmacist is waiting from the response of the Supply Chain Quality Team on the stability of the Pfizer vaccine lot # FP7139
1cm x 3cm erythematous area red warm to touch 10 days post vaccine.
C/o sever pain from bilateral shoulders to fingers and knees to toes fever 101'F, pain all day-worse at night. Taking Motrin for high temp.
Urticaria; This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (Urticaria) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included PROPRANOLOL HYDROCHLORIDE (INDERAL) for Blood pressure abnormal.   In January 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Urticaria). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, URTICARIA (Urticaria) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient had been experiencing an itchy rash, and the itchiness still had not gone away. It was a big purple rash, with urticaria. Dermatologist had looked at it and did not know what to do. Patient was still experiencing the itchiness and it was bothering her.   This case was linked to MOD-2022-550703 (Patient Link).
On 3-7-2021 I woke with most of my vivion gone from my right eye. I went into my Doctor's office as an emergency with in the hour and was seen originally by Dr.
In less than 24 hours, fever, painful chills, headache, stuffy nose, aches, sweating, nausea, weak,
pt recvd vax 11OCT95 & 13OCT sore throat;14OCT fever 101; gen aches-swollen glands, h/a & dec sore throat;15OCT non productive cough, laryngitis;16OCT-17OCT fatigue, cough-no fever
Noticed my left armpit was slightly swollen a few hours after getting 2nd vaccine. I woke up the next day and it is visibly swollen and uncomfortable.  Took Advil before bedtime but no change noted.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 30-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Headache 6 hours after injection lasting 24 hours, pain, itching and redness at injection site starting 8 hours after injection and continuing at this time, nodule at injection site and continuing at this time.  No medical treatment sought.
1 weekafter receiving an injection of FLU SHIELD(1996-97 Formula), the patient developed lymphadenopathy, joint pain and pain in her right arm. The lymphadenopathy resolved, but the pain persisted as of 7/15/97. An "extensive work-up" to determine the cause of the pain has been "negative". The patinet was taking hydrocodone with acetaminiphen 10MG/650MG three times daily and as needed for pain relief.
This spontaneous case was reported by a non-health professional and describes the occurrence of ILLNESS (very sick) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The reporter was a sister to the male patient. No medical history and patient information were provided. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very sick). At the time of the report, ILLNESS (very sick) had resolved. The reporter was a sister to the male patient. No medical history and patient information were provided. The patient did not seek medical intervention  This case was linked to MOD-2021-129280.
This case is a cluster of 2 patients who experienced adverse events following administration of ADACEL; lot number C4023AA. The events for the other patient was captured in case number 2012-00781. Initial report was received from a healthcare professional on 20 January 2012. A female patient (age not reported) had received an injection of ADACEL; sanofi pasteur Ltd. lot number C3023AA. On an unspecified date following vaccination, the patient developed redness, swelling and pain in arm. It is unknown is the patient received any corrective treatment. No further information was available at the time of this report. The patient outcome was not reported. Documents held by sender: none.
Fever 3 days; congestion x 3 days; rash day 10 post vax;